semaglutide
Show Tirzepatide Beats Semaglutide vs Heart Death
Tirzepatide reduces cardiovascular mortality more than semaglutide, cutting heart-related deaths by roughly 20% versus a 6% drop in comparable patients. This advantage emerges from recent VERTIS-CV data and could shift how clinicians protect diabetic hearts. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice.